Naturalness and Healthiness Offering the Company Stronger International Competitiveness

Anhui Hegeng Biotech Engineering Co., Ltd. ("Hegeng Biotech") received an interview after a successful closing of CPhI China 2019.

Core products mainly brought by Hegeng Biotech to the CPhI this year included L-arabinose, D-galactose, L-rhamnose monohydrate, and D-glucuronic acid. The products produced by Hegeng Biotech have some advantages in the current market, because the sources are different from those of other suppliers in China. All the products have passed KOSHER and HALAL inspections and obtained the corresponding certificates. The L-arabinose produced by the company is fully from the natural forest products without any risk of GMO. Neither Hegeng nor any of Hegeng’s suppliers of raw materials has used Genetically Modified Organisms in this product. In the whole production process,only water is used as extraction solvent to ensure the environmental sustainability and the process safety. The D-galactose produced by Hegeng Biotech is from plant sources with low endotoxin and is especially suitable for biopharmacy. The endotoxin is controlled at a very level to meet special requirement less than 5 EU/g or more stricter requirement and make sure to provide the best raw material for biopharmaceutical products. The L-rhamnose monohydrate produced by Hegeng Biotech is directly extracted from natural forest products with stable yield and advanced process and without any organic solvent in the whole process.

 
Core products mainly brought by Hegeng Biotech to the CPhI this year
included L-arabinose, D-galactose, L-rhamnose monohydrate, and D-glucuronic acid.

The company uses GMP standard as our product quality control and management measure to strictly implement. and, to regulate the quality regulation process and achieve quality controllability. Adhering to the idea of "quality first, integrity-based", Hegeng Biotech has established a sound quality management system by improving the quality control ability, establishing a document system, conducting quality retrospective analysis and personnel quantitative assessment, controlling and saving costs, monitoring inspection processes, sharing resources, and tracking product stability, etc., to make sure of product traceability and consistency. The saccharification production facility of Hegeng Biotech received the U.S. FDA’s site inspection and audit in 2018 and was recognized as conforming to the requirements. All featured products of Hegeng, such as L-arabinose, D-galactose, and L-rhamnose monohydrate, have received DMF numbers.

 
Anhui Hegeng Biotech Engineering Co., Ltd.

Annual sales of the three products featured by Hegeng Biotech this time are overall growing, although not as expected by the company yet. The staff of the company keeps the faith, actively advocates the concepts of less sugar and healthiness and truly brings food raw materials, APIs and cosmetic raw materials with high quality and guaranteed safety to the customers, to guarantee their market supply side to be stable, safe, and efficient. Some customers have understood and gradually tried products of Hegeng. Hegeng Biotech, a professional health supply company,  believes that Hegeng products will be accepted by the market to gradually substitute the original raw material products with low prices but high risks, after they undergo the process of customers’ test, feasibility study, downstream product market acceptance, and meeting expectations for enterprise benefits.

 
Anhui Hegeng Biotech Engineering Co., Ltd.

In this exhibition, customers recognized the quality of the products from plant sources and were very interested in understanding Hegeng’s corporate culture, core product test reports, and quality certificates obtained by Hegeng. Some customers have established business contact with the company to become potential customers. The biggest gain of the company from the exhibition was understanding the new dynamics of the international market while recommending products and services to Chinese and overseas customers, which has made the staff of Hegeng Biotech full of confidence, to spur themselves to conduct continuous optimization to make the company more competitive in the world. Looking to the future, Hegeng Biotech will operate attentively and control quality as always, to show Hegeng’s strength to all the customers. Hegeng Biotech will continue to serve the broad customers in the SSW exhibition this October and CPhI Germany exhibition this November. Industry elites are welcome to exchange ideas with and give suggestions for the company so that the company can accumulate strength to further expand the market.

Anhui Hegeng Biotech Engineering Co., Ltd.

Anhui Hegeng Biotech Engineering Co., Ltd.

Established in Oct. 2017, Anhui Hegeng Biotech Engineering Co., Ltd. is a technology-intensive enterprise that integrates basic R&D, derivative application, and product production and sales and focuses on R&D, production and sales of monosaccharide bio-based materials and oligosaccharide synthesized derivative materials. The enterprise possesses independent intellectual property in many technologies and products, has solid strength in independent R&D and continuous sci-tech innovation and boasts a self-owned project R&D and test platform. The enterprise has independently developed and designed its overall production process, with the complete separation and conversion of "isomer" as its core technology. Its functional oligosaccharides have been applied in many areas in and outside China, mainly including the pharmaceutical area (important intermediates of antiviral, antitumor and anti-HAV drugs, etc., and main carrier materials of antitumor drugs, etc.), health food area (synthesized in health food for blood sugar regulation and diabetes, and new flavor and fragrance additives of food, etc.), and cosmetics area (main raw materials for synthesizing hyaluronic acid, etc.)